Quarterly report · Q3
6523.TEDINET S100Q6BS
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥265.1bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥94.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥340.5bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥252.4bn | 2021-04-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥86.3bn | 2021-10-01 → 2021-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥21.4bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥10.9bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥24.1bn | 2021-04-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥10.5bn | 2021-10-01 → 2021-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥7.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥4.0bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥24.9bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥4.8bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥3.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥8.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥18.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.5bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥2.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥18.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥3.6bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥569.9bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥591.3bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥595.1bn | at 2021-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥431.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥455.3bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥138.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥136.1bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥152.1bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥107.6bn | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥137.9bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥135.4bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥151.5bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥59.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥95.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.0bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥60.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥6.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥51.1bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥36.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥11.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥12.5bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥9.4bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥32.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥7.0bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥106m | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥27.33 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥17.69 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-70.78 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥156.67 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥28.83 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥27.07 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥17.53 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-70.78 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥152.82 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥28.34 | 2021-10-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 24.2% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 22.9% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 25.5% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥13.0bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥83.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥83.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.7bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥80.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥80.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥99.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥99.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.5bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥263.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥263.3bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥34.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥11.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥82.3bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥82.3bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥18.7bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥68.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥68.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥99.6bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥99.6bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥12.4bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥250.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥250.3bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥35.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 934
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)梅谷哲史 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)花岡克典 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)西垣内 琢也 | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior1YTDDuration | 252368000000 | JPY |
| Revenue IFRS (5-year summary) | CurrentYTDDuration | 265102000000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 340452000000 | JPY |
| Revenue IFRS (5-year summary) | Prior1QuarterDuration | 86317000000 | JPY |
| Revenue IFRS (5-year summary) | CurrentQuarterDuration | 94517000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YTDDuration | 24907000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYTDDuration | 7414000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 3002000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 18513000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | 3403000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | -8460000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1QuarterDuration | 3521000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentQuarterDuration | 2208000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 21497000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | 11291000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 3506000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1QuarterInstant | 151494000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | CurrentQuarterInstant | 137947000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 135374000000 | JPY |
| Total assets IFRS (5-year summary) | Prior1QuarterInstant | 595142000000 | JPY |
| Total assets IFRS (5-year summary) | CurrentQuarterInstant | 569887000000 | JPY |
| Total assets IFRS (5-year summary) | Prior1YearInstant | 591320000000 | JPY |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 156.67 | |
| Basic earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | 27.33 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YearDuration | -70.78 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1QuarterDuration | 28.83 | |
| Basic earnings loss per share IFRS (5-year summary) | CurrentQuarterDuration | 17.69 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 152.82 | |
| Diluted earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | 27.07 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YearDuration | -70.78 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1QuarterInstant | 0.255 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | CurrentQuarterInstant | 0.242 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1YearInstant | 0.229 | |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YTDDuration | 36027000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | CurrentYTDDuration | 6856000000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YearDuration | 51053000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YTDDuration | -9427000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | CurrentYTDDuration | -11265000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -12521000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YTDDuration | 106000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | CurrentYTDDuration | -32874000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | -7015000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1QuarterInstant | 87988000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | CurrentQuarterInstant | 59368000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |